Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Trusheim

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2017
Characterization of annual disease progression of multiple sclerosis patients: A population-based studyJonatan Freilich, Ali Manouchehrinia, Mark Trusheim, et al.
Drug Discovery Today|November 26, 2020
Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutionsEline van Overbeeke, Sissel Michelsen, Mondher Toumi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 28, 2025
When Do Value-Based Contracts Add Value? Insights From Probabilistic SimulationsRebecca K Metcalfe, Karen Geary, Mark Trusheim, et al.
Drug Discovery Today|January 19, 2016
Translational Medicine Guide transforms drug development processes: the recent Merck experienceHugues Dolgos, Mark Trusheim, Dietmar Gross, et al.
Clinical Pharmacology and Therapeutics|October 30, 2021
Precision Reimbursement for Precision Medicine: Using Real-World Evidence to Evolve From Trial-and-Project to Track-and-Pay to Learn-and-PredictHans-Georg Eichler, Mark Trusheim, Brigitte Schwarzer-Daum, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 16, 2023
Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countriesZoltán Kaló, Maciej Niewada, Tamás Bereczky, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to ImplementationDuane Schulthess, Lynn G Baird, Mark Trusheim, et al.
Clinical Pharmacology and Therapeutics|September 22, 2021
A Useful and Sustainable Role for N-of-1 Trials in the Healthcare EcosystemHarry P Selker, Theodora Cohen, Ralph B D'Agostino, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2017
Characterization of annual disease progression of multiple sclerosis patients: A population-based studyJonatan Freilich, Ali Manouchehrinia, Mark Trusheim, et al.
Drug Discovery Today|November 26, 2020
Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutionsEline van Overbeeke, Sissel Michelsen, Mondher Toumi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 28, 2025
When Do Value-Based Contracts Add Value? Insights From Probabilistic SimulationsRebecca K Metcalfe, Karen Geary, Mark Trusheim, et al.
Drug Discovery Today|January 19, 2016
Translational Medicine Guide transforms drug development processes: the recent Merck experienceHugues Dolgos, Mark Trusheim, Dietmar Gross, et al.
Clinical Pharmacology and Therapeutics|October 30, 2021
Precision Reimbursement for Precision Medicine: Using Real-World Evidence to Evolve From Trial-and-Project to Track-and-Pay to Learn-and-PredictHans-Georg Eichler, Mark Trusheim, Brigitte Schwarzer-Daum, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 16, 2023
Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countriesZoltán Kaló, Maciej Niewada, Tamás Bereczky, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to ImplementationDuane Schulthess, Lynn G Baird, Mark Trusheim, et al.
Clinical Pharmacology and Therapeutics|September 22, 2021
A Useful and Sustainable Role for N-of-1 Trials in the Healthcare EcosystemHarry P Selker, Theodora Cohen, Ralph B D'Agostino, et al.
Pageof 2